Continuous Glucose Monitoring Systems Market Share, Growth | Forecast 2024-2032

Comments · 49 Views

The continuous glucose monitoring systems market was valued at US$ 11.4 Billion in 2023 and is expected to register a CAGR of 15.3% over the forecast period and reach US$ 41.1 Bn in 2032.

The Reports and Insights, a leading market research company, has recently releases report titled “Continuous Glucose Monitoring Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global Continuous Glucose Monitoring Systems Market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the Continuous Glucose Monitoring Systems?

The continuous glucose monitoring systems market was valued at US$ 11.4 Billion in 2023 and is expected to register a CAGR of 15.3% over the forecast period and reach US$ 41.1 Bn in 2032.

What are Continuous Glucose Monitoring Systems Market?

Continuous Glucose Monitoring (CGM) Systems are devices worn on the body to monitor glucose levels continuously. These systems include a small sensor inserted under the skin, usually on the abdomen, to measure glucose levels in the interstitial fluid. The sensor is connected to a transmitter that sends the glucose readings to a receiver or smartphone app. CGM systems offer real-time glucose readings, trends, and alerts for high and low glucose levels, aiding people with diabetes in managing their condition more effectively. They are particularly useful for individuals requiring strict glucose control, such as those with type 1 diabetes, as they can help prevent episodes of hypoglycemia and hyperglycemia.

Request for a sample copy with detail analysis: https://www.reportsandinsights.com/sample-request/2333

What are the growth prospects and trends in the Continuous Glucose Monitoring Systems Market industry?

The continuous glucose monitoring (CGM) systems market growth is driven by various factors and trends. The market for continuous glucose monitoring (CGM) systems is experiencing significant growth due to several factors, including the increasing global prevalence of diabetes, greater adoption of advanced diabetes management technologies, and a rising demand for real-time glucose monitoring solutions. CGM systems offer numerous benefits compared to traditional glucose monitoring methods, such as continuous monitoring, trend analysis, and alerts for high and low glucose levels. Market expansion is further driven by factors like the development of innovative CGM systems, their integration with smartphones and other devices for data management, and favorable reimbursement policies for diabetes management devices. Moreover, the trend towards personalized and proactive healthcare approaches is expected to continue driving the demand for CGM systems in the future. Hence, all these factors contribute to continuous glucose monitoring (CGM) systems market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

By Components

  • Transmitters and Monitors
  • Sensors
  • Receiver

By Technology

  • Real Time continuous glucose monitoring
  • Intermittently Scanned continuous glucose monitoring

By Application

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes

By End-Use

  • Home Care Diagnostics
  • Hospitals
  • Ambulatory Surgical Centers

By Region

North America

  • United States
  • Canada

Europe

  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Russia
  • Poland
  • Benelux
  • Nordic
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • ASEAN
  • Australia New Zealand
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina

Middle East Africa

  • Saudi Arabia
  • South Africa
  • United Arab Emirates
  • Israel
  • Rest of MEA

Who are the key players operating in the industry?

The report covers the major market players including:

  • Dexcom
  • Medtronic
  • Abbott
  • Trinity Biotech
  • Senseonics
  • Ypsomed
  • Life Scan
  • Roche
  • Novo Nordisk
  • Pendragon Medical
  • NOW Health
  • Nutramax Laboratories
  • Ascensia Diabetes Care
  • Pendragon Medical
  • Omnipod
  • Medella Health

Discover more: https://www.reportsandinsights.com/report/continuous-glucose-monitoring-systems-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

Reports and Insights consistently mееt international benchmarks in the market research industry and maintain a kееn focus on providing only the highest quality of reports and analysis outlooks across markets, industries, domains, sectors, and verticals. We have bееn catering to varying market nееds and do not compromise on quality and research efforts in our objective to deliver only the very best to our clients globally.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

Reports and Insights Business Research Pvt. Ltd.
1820 Avenue M, Brooklyn, NY, 11230, United States
Contact No: +1-(347)-748-1518
Email: [email protected]
Website: https://www.reportsandinsights.com/
Follow us on LinkedIn: https://www.linkedin.com/company/report-and-insights/
Follow us on twitter: https://twitter.com/ReportsandInsi1

Comments